Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: Prospective randomized trial

被引:98
作者
Salas, Sebastien [2 ]
Baumstarck-Barrau, Karine [1 ]
Alfonsi, Marc [3 ]
Digue, Laurence [2 ]
Bagarry, Danielle [2 ]
Feham, Nasreddine [4 ]
Bensadoun, Rene Jean [5 ]
Pignon, Thierry [6 ]
Loundon, Anderson [1 ]
Deville, Jean-Laurent [2 ]
Zanaret, Michel [7 ]
Favre, Roger [2 ]
Duffaud, Florence [2 ]
Auquier, Pascal [1 ]
机构
[1] APHM, Sante Publ EA 3279, Serv Sante Publ & Informat Med, Marseille, France
[2] CHU Timone, APHM, Serv Oncol Med Adulte, Marseille, France
[3] Inst St Catherine, Serv Radiotherapie, Avignon, France
[4] Ctr Hosp Louis Pasteur, Serv Radiotherapie, Colmar, France
[5] Ctr Antoine Lacassagne, Serv Radiotherapie, F-06054 Nice, France
[6] CHU Timone, APHM, Serv Radiotherapie, Marseille, France
[7] CHU Timone, APHM, Serv ORL & Chirurg Cervicofaciale, Marseille, France
关键词
Head and neck carcinoma; Racho-chemotherapy; Quality of life; Prophylactic gastrostomy; Randomized trial; KARNOFSKY PERFORMANCE STATUS; STAGE OROPHARYNX CARCINOMA; CANCER-PATIENTS; RADIATION-THERAPY; WEIGHT-LOSS; LARYNGEAL-CANCER; HEALTH SURVEY; RADIOTHERAPY; CHEMOTHERAPY; ONCOLOGY;
D O I
10.1016/j.radonc.2009.05.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: concomitant radio-chemotherapy is the gold standard treatment for unresectable head and neck carcinomas Placement of prophylactic gastrostomy has been proposed to provide adequate nutution during the therapeutic sequence The objectives of this study were to assess the impact of prophylactic gastrostomy on the 6-month quality of life, and to determine the factors related to this quality of life Materials and methods Design. randomized. controlled, open study (systematic percutaneous gastrostomy" versus "no systematic gastrostomy") Patients squamous cell head and neck carcinoma (stages III and IV. UICC 1997) Setting oncological departments of French university teaching hospitals Treatment optimal concomitant radio-chemotherapy. Evaluations. T0 baseline evaluation, T1 during the treatment. T2 end of the treatment, and T3 6-month post-inclusion Primary endpoint 6-month quality of life (Qol) assessed using SF36. EORTC QLQ-C30. EORTC QLQ H&NN35 questionnaires Results The Qol changes from baseline included a decline (T1 arid T2) followed by an improvement (T3) Qol at 6 months was significantly higher in the group receiving systematic prophylactic gastiostomy (p= 10(3)) Higher initial BMI arid lower initial Karnofsky index were significant factors related to a higher 6-month Qol Conclusions The study results suggest that prophylactic gastiostomy improves post-treatment quality of life for unresectable head and neck cancer patients, after adjusting for other potential predictive quality of life factors (C) 2009 Elsevier Ireland Ltd All rights reserved Radiotherapy anti Oncology 93 (2009) 503-509
引用
收藏
页码:503 / 509
页数:7
相关论文
共 51 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]  
Adelstein DJ, 2003, EXPERT OPIN PHARMACO, V4, P2151, DOI 10.1517/14656566.4.12.2151
[3]  
[Anonymous], MOS SF36 QUESTIONNAI
[4]   Predictors of weight loss during radiation therapy [J].
Beaver, ME ;
Matheny, KE ;
Roberts, DB ;
Myers, JN .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2001, 125 (06) :645-648
[5]  
Bieri S, 2003, STRAHLENTHER ONKOL, V179, P390, DOI 10.1007/s00066-003-1077-1
[6]   DEVELOPMENT OF A EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC) QUESTIONNAIRE MODULE TO BE USED IN QUALITY-OF-LIFE ASSESSMENTS IN HEAD AND NECK-CANCER PATIENTS [J].
BJORDAL, K ;
AHLNERELMQVIST, M ;
TOLLESSON, E ;
JENSEN, AB ;
RAZAVI, D ;
MAHER, EJ ;
KAASA, S .
ACTA ONCOLOGICA, 1994, 33 (08) :879-885
[7]   Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma [J].
Calais, G ;
Alfonsi, M ;
Bardet, E ;
Sire, C ;
Germain, T ;
Bergerot, P ;
Rhein, B ;
Tortochaux, J ;
Oudinot, P ;
Bertrand, P .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (24) :2081-2086
[8]  
COSTE J, 2001, MED OUTCOME STUDY SH
[9]   NUTRITIONAL REHABILITATION IN PATIENTS WITH ADVANCED HEAD AND NECK-CANCER RECEIVING RADIATION-THERAPY [J].
DALY, JM ;
HEARNE, B ;
DUNAJ, J ;
LEPORTE, B ;
VIKRAM, B ;
STRONG, E ;
GREEN, M ;
MUGGIO, F ;
GROSHEN, S ;
DECOSSE, JJ .
AMERICAN JOURNAL OF SURGERY, 1984, 148 (04) :514-520
[10]  
DAntonio LL, 1996, ARCH OTOLARYNGOL, V122, P482